Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Mini Review Volume 6 Issue 5

An Update on Etiology of Chronic Kidney Disease with Role of Associated Vitamin K Deficiency in Prevention of Vascular Calcification and Cardiovascular Risks and Avoid Mortality: A Minireview

Kulvinder Kochar Kaur*, Gautam Allahbadia and Mandeep Singh

Department of Obstetrics and Govil, Pecialist Reproductive Endocrinology and Infertility, Dr Kulvinder Kaur Centre for Human Reproduction, India

*Corresponding Author: Kulvinder Kochar Kaur, Department of Obstetrics and Govil, Pecialist Reproductive Endocrinology and Infertility, Dr Kulvinder Kaur Centre for Human Reproduction, India.

Received: March 16, 2022; Published: April 22, 2022



Vitamin K possesses numerous significant role in human health. More recently researchers have a established that healthy diet consumption possessing good fats, Vitamins, minerals, polyphenolics possesses anti-inflammatory actions can act in antiaging role. Earlier the belief was that Vitamin K acts basically as an anticoagulant, besides part in calcium homeostasis. Having reviewed the etiology in chronic kidney disease (CKD), Diabetic Kidney Disease (DKD)with those patients presenting with DKD- CKD or end stage renal Disease (ESRD), in addition to details of associated Vascular calcification, acute kidney injury here we tried to further update knowledge regarding role of Vitamin K deficit in deterioration of CKD in particular the ones associated with Vascular calcification (VC). Vitamin K plays a significant role as a co- factor in transformation of glutamate to Gla. This has a significance in hampering of VC. CKD patients both on dialysis as well as not on dialysis generally possess Vitamin K deficiency. Enhancement of uncarboxylated matrix Gla protein [MGP] (uc MGP) indirectly points to Vitamin K deficiency as well as correlated with a greater chance of generation of the cardiovascular processes. It has been pointed that greater Vitamin K consumption might cause avoidance of development of VC, besides reduction in CV risk. Thus we did a minireview utilizing the search engine pubmed, google scholar and other sutilizing the MeSH terms like DKD; CKD; Vitamin K ; Growth arrest specific protein 6 (Gas6); VC; hemodialysis (HD) patients from 2000 till date in 2022. We found s total of 65 articles with regards to CKD, Vitamin K, out of which we chose50 articles for this minireview. Despite all the research till date role of supplementation of Vitamin K with dosage, kinds still not clear that is varying from country to country as well as source VK1 or2. Still greater large RCTs are required to settle that query.


Keywords: Vitamin K; uc MGP; CKD; VK Supplementation; VC; Gas61



  • Maurya PK., et al. “Role of Oxidative stress in erythrocytes as a function of human age”. World Journal of Methodology 5 (2015): 216-222.
  • Rusu ME., et al. “Antiaging potential of tree nuts with a focus on phytochemical composition, molecular mechanisms and thermal stability of major bioactive compounds”. Food and Function journal 9 (2018): 2554-2575.
  • Harshman S and Shea M. “Vitamin K in chronic aging diseases: inflammation, cardiovascular disease, and osteoarthritis”. Current Nutrition Reports 5 (2016): 90-98.
  • Braasch-Turi M and Crans DC. “Synthesis of naphthoquinone derivatives: menaquinone, lipaquinone and other Vitamin K derivatives”. Molecules 25 (2020):
  • Popa DS., et al. “The role of Vitamin K in humans: implications in aging and age associated diseases”. Antioxidants 10 (2021):
  • Turck D., et al. “Dietary reference values for Vitamin K”. EFSA Journal 15 (2017):
  • Mense-Boonstra A., et al. “Bioavailability of micronutrient from Nutrient -dense whole foods zoom in in the dairy, vegatables, and fruits”. Frontiers in Nutrition 7 (2020):
  • Margier M., et al. “Meal can alter fat soluble Vitamin Bioavailability”. Molecular Nutrition and Food Research 6 (2019):
  • Halder M. “Vitamin K: double bonds beyond congratulation insights into the differences between Vitamin K1 and Vitamin K2 in health and disease”. International Journal of Molecular Sciences 20 (2019): 896.
  • Wei FF., et al. “Vitamin K dependent matrix Gla protein as multifaceted protector of vascular and tissue integrity”. Hypertension 73 (2019): 1160-1169.
  • Grober U., et al. “Vitamin K:an old Vitamin in a new perspective”. Endocrinology in Dermatology 6 (2015):
  • Bender D. Vitamin K. “Nutritional Biochemistry of Vitamins”. Cambridge University Press: Cambridge, UK, (2003): 131-147.
  • Simes D., et al. “Vitamin K as a diet supplementation with impact in human health: current evidence in age-related diseases”. Nutrients 12 (2020):
  • Li., et al. “Role of Vitamin Kin preventing Oxidative injury to developing oligodendrocytes and neurons”. Journal of Neuroscience 23 (2020): 5816-5826.
  • Sinbad OO., et al. “Vitamins as anti-oxidants”. Journal of Food Science and Nutrition 2 (2019): 214-235.
  • Rusu ME., et al. “Benefits of tree nuts consumption on aging and age related diseases”. Trends in Food Science and Technology 88 (2019): 104-120.
  • Fusaro M., et al. “Vitamin K plasma levels determination in human, health”. Clinical Chemistry and Laboratory Medicine 55 (2017): 789-799.
  • Dinicolantonio JJ., et al. “The health benefit s of Vitamin K”. Open Heart 2 (2015): e000300.
  • Akbulut K., et al. “Vitamin K2 needs an RDI separate from Vitamin K1”. Nutrients 12 (2020):
  • Kim Y., et al. “Benefits of nuts consumption on insulin resistance and cardiovascular risk factors: multiple potential mechanisms of action”. Nutrients 9 (2017):
  • Kulvinder Kochar Kaur., et al. “An Update on the Approaches of Avoidance of Propagation of Chronic Kidney Disease resulting in Reversal or Prevention of Kidney transplantation-A Systematic Review”. Under Review (2022).
  • Kulvinder Kochar Kaur., et al. “Potential role of Epigenetic Modulation in prevention or therapy for Diabetic Kidney Disease-still a dream or a reality -A Systematic Review”. J Diab Nephro Diab Mgmt 1 (2021): 11-26.
  • Kulvinder Kochar Kaur., et al. “An update in the utilization of N-acetylcysteine and vitamin c for tackling the oxidative stress in acute kidney injury secondary to robustsepsis - A systematic review”. Journal of Clinical Nephrology 6 (2022): 001-018.
  • Stopien A., et al. “Biological role of Vitamin K - with particular emphasis on cardiovascular and renal aspects”. Nutrients 14 (2022):
  • Silaghi CN., et al. “Vitamin K- dependent proteins in kidney disease”. International Journal of Molecular Sciences 20 (2019):
  • Xiao H., et al. “Role of emerging Vitamin K- dependent proteins: growth arrest specific protein 6, Gla rich protein and periostin (Review)”. International Journal of Molecular Medicine 47 (2021):
  • Ravindra BN., et al. “Chronic Kidney Disease: role of Vitamin K and Vitamin D”. CMRO 47 (2021):
  • Niemick U., et al. “Multifaceted function of Vitamin K with particular consideration of Vitamin K2-literature Review: Pomeranian”. Journal of Life Sciences 66 (2020): 39-44.
  • Stefanos Roumeliotis S., et al. “Vascular calcification in Chronic Kidney Disease: the role of Vitamin K dependent matrix Gla protein”. Frontiers in Medicine 7 (2020):
  • Puzantian H., et al. “Circulating dephospho- uncarboxylated matrix Gla protein is associated with Kidney dysfunction and arterial stiffness”. American Journal of Hypertension 31 (2018): 988-994.
  • Wen L., et al. “Vitamin K- dependent proteins involved in bone and cardiovascular health”. Molecular Medicine Reports 18 (2018): 3-15.
  • Caluwe R., et al. “evaluation of Vitamin K status and rationale for Vitamin K supplementation in dialysis patients”. Nephrology Dialysis Transplantation 35 (2020): 23-32.
  • Brandenburg V., et al. “Slower progression of aortic valve calcification with Vitamin K supplementation: result from a prospective interventional proof of concept study”. Circulation 135 (2017): 2081-2084.
  • Zhang., et al. “Vitamin K status and cardiovascular events or mortality: a meta-analysis”. European Journal of Preventive Cardiology 26 (2019): 549-553.
  • Chen H., et al. “Association of Vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis”. European Journal of Nutrition 58 (2019): 2195-2205.
  • Cozzolino M., et al. “Current therapy in CKD patients can affect Vitamin K status”. Nutrients 12 (2020):
  • Fusaro M., et al. “Vitamin K and Kidney transplantation”. Nutrients 12 (2020):
  • Turner ME., et al. “The Vitamin K metabolome in chronic kidney disease”. Nutrients 10 (2018):
  • Giangola MD., et al. “Growth arrest specific protein 6 protects arterial against renal ischemia-reperfusion injury”. Journal of Surgical Research 199 (2015): 572-579.
  • Dai., et al. “Vitamin K insufficiency, Vascular calcification and mortality inadvanced chronic kidney disease: A cohort study”. PLOS ONE 16 (2021): e247523.
  • , et al. “Growth arrest specific protein 6 is involved in glomerular hypertrophy in the early stage of Diabetic nephropropathy”. Journal of Biological Chemistry 278 (2003): 18229-18234.
  • Hung YJ., et al. “Plasma protein Growth arrest specific protein 6 levels are associated with altered glucose tolerance, inflammation and endothelial dysfunction”. Diabetes Care 35 (2010): 1840-1844.
  • , et al. “Growth arrest specific protein 6 (Gas 6) as a noninvasive Biomarker for early detection of Diabetic nephropropathy”. Clinical and Experimental Hypertension 39 (2017): 382-387.
  • Liabeul S., et al. “Vascular calcification in patients withtype2 diabetes: involvement of matrix Gla protein”. Cardiovascular Diabetology 13 (2014):
  • Roumeiotis S., et al. “Association of dp-ucMGP with cardiovascular morbidity and dereased renal function in Diabetic Kidney Disease”. International Journal of Molecular Sciences 21 (2020):
  • Riphagen., et al. “Prevalence and effects of functional Vitamin K insufficiency: The PREVEND) study”. Nutrients 9 (2017):
  • Dai., et al. “Early vascular aging in Chronic Kidney Disease:impact of inflammation Vitamin K, Senescence and genomic damage”. Nephrology Dialysis Transplantation 35 (2020): 1131-1137.
  • Sardana M., et al. “Inactive matrix Gla protein and arterial stiffness intype2 diabetes mellitus”. American Journal of Hypertension 30 (2016): 196-201.
  • Aoun M., et al. “Dephosphorylated uncarboxylated MGP in haemodialysis patients: risk factors and response to Vitamin K2. A pre-post intervention Clinical trial”. BMC Nephrology 18 (2017):
  • Nigwekar SU., et al. “Vitamin K dependentcarboxylation pf matrix Gla protein influences the risk of calciphylaxis”. Journal of the American Society of Nephrology 28 (2017): 1717-1722.
  • ×


    Citation: Kulvinder Kochar Kaur., et al. “An Update on Etiology of Chronic Kidney Disease with Role of Associated Vitamin K Deficiency in Prevention of Vascular Calcification and Cardiovascular Risks and Avoid Mortality: A Minireview".Acta Scientific Nutritional Health 6.5 (2022): 82-91.


    Acceptance rate30%
    Acceptance to publication20-30 days
    Impact Factor1.316

    Indexed In

    News and Events

    Contact US